Saturday 17 October 2026
Export MDXHF’s income statement to Excel — free account
MedX Health Corp.
MDXHF Healthcare Diagnostics & Research
MedX Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $338,700.00, down 5.23% from fiscal 2024. In the quarter to June 2026, revenue grew 33.6%, EPS fell 6.06%, free cash flow grew 41.6% and total debt fell 8.75%, each against the same quarter a year earlier.
0.03
0.00
0.00%
Follow MDXHF
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 5 | 4 | 6 | 3 | 2 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.26 | 0.01 | 0.02 | 0.00 | 8.75 |
Altman Z-Score |
(1.89) | — | (5.20) | (11.51) | (11.30) | (4.49) | (4.07) | (3.57) | (104.48) | (157.11) |
Altman Z″-Score (non-manufacturers) |
0.24 | — | (6.04) | (22.86) | (25.44) | (6.88) | (9.46) | (8.78) | (274.96) | (415.54) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(0.47) | (0.47) | (0.47) | (0.49) | (0.40) | (1.68) | (0.03) | (0.15) | 0.00 | (3.70) |
Beneish M-Score |
— | — | — | — | (4.84) | (2.76) | 0.63 | (2.86) | (14.89) | — |
P/B ratio |
0.17 | 0.17 | 0.17 | 0.23 | 1.40 | 0.20 | 0.03 | 0.15 | 0.00 | 0.00 |
Price to Tangible BV |
0.27 | 0.27 | 0.27 | 0.36 | 10.32 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.24 | (0.95) | 0.63 | 0.26 | 5.93 | 12.29 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 4.33 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (0.13) | 0.63 | (0.69) | (0.86) | (1.16) | (1.56) |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 | (0.13) | 0.63 | (0.60) | (0.62) | (0.47) | (0.79) |
Quick Ratio |
3.93 | 2.80 | 3.95 | 2.76 | 1.51 | 3.84 | 1.36 | 1.71 | 0.05 | 0.01 |
Current Ratio |
4.09 | 3.00 | 4.17 | 2.96 | 1.77 | 4.05 | 1.59 | 1.95 | 0.10 | 0.04 |
Net Debt/EBITDA |
2.80 | 1.48 | 0.87 | 0.33 | 0.04 | 1.84 | (0.66) | (0.85) | (1.29) | (0.40) |
Debt/Assets |
0.79% | 0.00% | 0.80% | 27.08% | 47.44% | 19.60% | 32.42% | 30.81% | 346.44% | 241.50% |
Debt/Equity |
0.01 | 0.02 | 0.01 | 0.56 | 2.58 | 0.31 | 4.15 | 5.52 | (0.36) | (0.17) |
Asset Turnover |
0.45 | 1.28 | 0.46 | 0.22 | 0.48 | 0.42 | 0.38 | 0.57 | 0.01 | 0.59 |
Operating CF/Net income |
1.26 | 0.85 | 0.89 | 0.52 | 0.71 | 0.78 | 0.77 | 0.50 | 0.69 | 0.59 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | (0.16) | (0.30) | (0.57) | (0.40) | (34.74) | (0.04) |
Interest Coverage |
(4,373.67) | — | (627.83) | (141.09) | (17.58) | (12.42) | (6.26) | (1.49) | (1.71) | (2.44) |
| (26.03%) | (27.25%) | (72.01%) | (118.02%) | (204.65%) | (109.96%) | (156.70%) | (521.70%) | (540.15%) | 68.26% | |
| (19.85%) | (38.84%) | (52.22%) | (80.10%) | (73.96%) | (54.25%) | (45.36%) | (34.72%) | (4.11%) | (784.34%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (338.36%) | (538.20%) | (77.00%) | (69.39%) | 0.00% | 0.00% |
Return on Tangible Assets |
(30.52%) | (45.47%) | (84.37%) | (187.95%) | (259.55%) | (55.94%) | (300.40%) | (182.67%) | 49.04% | 66.31% |
Average Days of Receivables |
237.51 | 168.69 | 245.91 | 207.35 | 74.56 | 75.20 | 92.17 | 57.66 | 219.06 | 97.96 |
Research and Development Expense of Revenue |
4.43% | 7.20% | 10.93% | 21.78% | 24.61% | 30.01% | 20.39% | 9.08% | 107.47% | 105.64% |
Selling, General and Administrative Expense of Revenue |
99.92% | 92.67% | 151.56% | 261.93% | 165.89% | 138.19% | 130.76% | 86.03% | 402.63% | 789.78% |
Intangible Assets out of Total Assets |
0.21 | 0.00 | 0.24 | 0.18 | 0.16 | 0.05 | 0.69 | 0.62 | 118.58 | 155.90 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 7.02% | 5.49% | 2.34% | 0.95% | 28.26% | 183.20% |
Graham Net Nets |
3.17 | 3.17 | 3.17 | 2.24 | (0.36) | 4.11 | (256.07) | (76.20) | 0.00 | (2.42) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.09 |
Earnings Yield |
(1,143.78%) | (1,143.78%) | (1,143.78%) | (1,143.78%) | (1,143.78%) | (899.17%) | (9,500.00%) | (2,850.00%) | 0.00% | (152.00%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | (677.37%) | (585.61%) | (12,294.31%) | (2,726.26%) | 0.00% | (178.45%) |
Revenue per Share |
0.62 | 0.87 | 5.67 | 2.12 | 2.22 | 0.18 | 2.36 | 2.70 | 0.00 | 0.00 |
Operating CF per Share |
(0.34) | (0.22) | (5.77) | (4.06) | (2.43) | (0.19) | (2.17) | (0.83) | (0.01) | (0.01) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (0.06) | (0.01) | (0.18) | (0.11) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.34) | (0.22) | (5.77) | (4.06) | (2.50) | (0.19) | (2.35) | (0.93) | (0.01) | (0.01) |
Cash per Share |
0.67 | 0.34 | 5.23 | 3.96 | 1.92 | 0.48 | 0.99 | 0.86 | 0.00 | 0.00 |
Shareholders Equity per Share |
1.14 | 0.88 | 10.40 | 3.54 | 0.70 | 0.39 | 0.59 | 0.28 | (0.02) | (0.02) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.14 | 0.88 | 10.40 | 3.54 | 0.70 | 0.39 | 0.59 | 0.28 | (0.02) | (0.02) |
Free Cash Flow |
(15.78) | (11.20) | (33.26) | (25.41) | (20.78) | (23.44) | (36.91) | (24.24) | (3.02) | (2.67) |
Working Capital |
38.82 | 26.29 | 41.82 | 23.01 | 10.07 | 50.17 | 10.87 | 18.64 | (5.46) | (7.00) |
Capital Expenditures |
(4.65) | (5.19) | (1.55) | (0.08) | (0.54) | (0.90) | (2.79) | (2.75) | (1.19) | 0.00 |
Net Current Asset Value |
36.43 | 24.42 | 39.66 | 11.24 | (2.92) | 38.43 | (80.67) | (83.76) | (6.25) | (7.18) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.22 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 | 0.08 | 0.04 | 3.32 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.62 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.73 | 0.78 | 1.42 | 1.39 | 3.42 | 1.82 | 1.29 | 1.38 | 1.19 | 0.18 |
Cash ROIC |
(18.79%) | (18.23%) | (36.70%) | (42.85%) | (56.29%) | (19.52%) | (58.18%) | (34.95%) | 78.05% | 46.51% |
Accounts Receivable Turnover |
1.48 | 2.24 | 1.55 | 0.90 | 3.27 | 5.32 | 5.32 | 6.87 | 0.06 | 2.22 |
Accounts Payable Turnover |
1.84 | 2.18 | 3.13 | 3.35 | 1.91 | 1.83 | 2.02 | 2.77 | 0.04 | 0.22 |
Inventory Turnover |
6.58 | 7.79 | 8.38 | 9.98 | 5.69 | 5.51 | 8.42 | 10.29 | 0.14 | 1.84 |
Average Days of Payables |
196.82 | 168.29 | 100.23 | 119.25 | 186.42 | 233.07 | 208.30 | 122.45 | 2,945.56 | 1,700.43 |
Days of Inventory on Hand |
48.15 | 53.07 | 45.21 | 28.67 | 81.44 | 59.74 | 47.62 | 38.62 | 465.22 | 130.17 |
Average Receivables |
19.28 | 19.28 | 20.99 | 14.76 | 5.65 | 4.18 | 6.97 | 10.22 | 5.65 | 0.15 |
Average Payables |
6.07 | 6.07 | 5.36 | 5.09 | 5.45 | 6.39 | 8.82 | 9.49 | 5.28 | 1.75 |
Average Inventory |
1.70 | 1.70 | 2.00 | 1.71 | 1.83 | 2.12 | 2.12 | 2.55 | 1.53 | 0.20 |
Average Assets |
63.15 | 33.79 | 71.42 | 60.45 | 38.75 | 53.46 | 97.10 | 124.13 | 64.89 | 0.57 |
Average Common Equity |
48.16 | 48.16 | 51.80 | 41.03 | 14.01 | 26.37 | 28.11 | 8.26 | 0.49 | (6.60) |
Columns are period end dates · fundamentals updated 2 Oct 2026